NCT06548906

A Study of GZR4 Injection at Different Injection Sites

A Trial Investigating the Pharmacokinetics, Pharmacodynamics and Safety of GZR4 Injection at Different Injection Regions in Healthy Subjects

• Status: Recruiting
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 24 (estimated)
• Sponsor: Gan and Lee Pharmaceuticals, USA · Industry
• Sex: Male
• Age: 18 Years – 55 Years
• Healthy volunteers: Accepted

Summary

This trial is conducted in China. This study is a randomized, single-center, open, three-period crossover trial in healthy subjects to compare the PK, PD, and safety of a single administration of GZR4 at different injection sites (abdomen, deltoid region of upper arm, and thigh).

Conditions

• Healthy Subjects

Interventions

Type	Name	Description
DRUG	GZR4 Injection	GZR4 Injection administered sc, once weekly.

Timeline

• Start date: 2024-05-08
• Primary completion: 2024-08-31
• Completion: 2024-08-31
• First posted: 2024-08-12
• Last updated: 2024-08-12

Locations

1 site across 1 country: China